Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.92
+1.03 (0.45%)
AAPL  277.18
-0.71 (-0.26%)
AMD  221.62
+0.51 (0.23%)
BAC  53.54
-0.36 (-0.67%)
GOOG  317.75
+3.30 (1.05%)
META  656.96
-9.84 (-1.48%)
MSFT  492.02
+1.00 (0.20%)
NVDA  184.97
-0.58 (-0.31%)
ORCL  221.53
+0.99 (0.45%)
TSLA  445.17
+5.59 (1.27%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.